Skip to content

13F-HR filed by SECTORAL ASSET MANAGEMENT INC

SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-10, with 56 holding rows worth $1,018,707,000.

Accession
0001104659-16-156249
Filed
2016-11-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 56 entries on the cover page, a total value of $1,018,707,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,018,707,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Merck & Co.,Inc.58933Y105COM925,170$57,740,000thousands by filing date
Pfizer Inc.717081103COM1,693,707$57,366,000thousands by filing date
CELGENE CORP151020104COM482,118$50,396,000thousands by filing date
Eli Lilly and Company532457108COM607,427$48,752,000thousands by filing date
Medtronic PlcG5960L103COM521,241$45,035,000thousands by filing date
Gilead Sciences,Inc.375558103COM524,165$41,472,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM802,979$40,663,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM411,317$38,055,000thousands by filing date
ABIOMED INC003654100COM253,745$32,627,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock1,419,208$32,230,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO166,093$32,199,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM4,194,452$31,039,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK1,199,869$29,985,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock576,769$28,579,000thousands by filing date
TELADOC HEALTH INC87918A105COM1,539,618$28,190,000thousands by filing date
DEXCOM INC COM252131107Stock321,502$28,183,000thousands by filing date
CIGNA CORPORATION125509109COM215,080$28,029,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM1,031,449$23,775,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock242,641$22,748,000thousands by filing date
INCYTE CORP COM45337C102Stock223,663$21,089,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR454,172$20,896,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM28,314$20,523,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM217,874$19,001,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR445,375$18,523,000thousands by filing date
OPHTHOTECH CORP683745103COM389,363$17,961,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM537,121$17,601,000thousands by filing date
ACCELERON PHARMA INC00434H108COM481,765$17,435,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM705,845$13,595,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS505,005$12,388,000thousands by filing date
NUVASIVE INC670704105COM179,960$11,996,000thousands by filing date
ACCURAY INC DEL004397105COM1,854,625$11,814,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM70,651$11,628,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM779,998$10,928,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM249,200$9,405,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM153,145$8,931,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock123,946$7,433,000thousands by filing date
KITE PHARMA INC49803L109COM116,326$6,498,000thousands by filing date
AMSURG CORP03232P405COM96,560$6,474,000thousands by filing date
TEAM HEALTH HOLDINGS INC87817A107COMMON STOCK185,560$6,042,000thousands by filing date
AVEXIS INC05366U100COM146,515$6,038,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW69,200$5,712,000thousands by filing date
SURGICAL CARE AFFILIATES INC COM86881L106Stock98,300$4,793,000thousands by filing date
ADVAXIS INC007624208COM NEW436,659$4,668,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM354,900$4,149,000thousands by filing date
REGENXBIO INC75901B107COM243,613$3,221,000thousands by filing date
NEURODERM LTDM74231107ORD SHS161,971$2,995,000thousands by filing date
ENTELLUS MED INC29363K105COM133,596$2,963,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM52,700$2,784,000thousands by filing date
INTERSECT ENT INC46071F103COM168,140$2,663,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM87,693$2,330,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM123,159$2,320,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM55,897$1,778,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock25,800$1,749,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR32,155$1,493,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR39,301$1,428,000thousands by filing date
Sierra Oncology, Inc.74346L101common201,660$399,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-16-156249this filing2016-11-10acceptance time not in the bulk data set